Sign in
4/A

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-048868

Chairman and CEO bought 20,000 shares at $3.19 ($63,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2019-08-29 Purchase +20,000 $3.19 $63,800 30,501 I
Open-market purchases · 20,000 sh · avg $3.19 · $63,800
Loading xslF345X03/doc4a.xml…